Allgens Medical Technology CO., LTD. (SHA:688613)
China · Delayed Price · Currency is CNY 20.50
+0.88 (4.49%)
Sep 29, 2026, 3:00 PM CST
SHA:688613 Revenue
Allgens Medical Technology CO., LTD. had revenue of 55.38M CNY in the quarter ending June 30, 2026, a decrease of -3.81%. This brings the company's revenue in the last twelve months to 227.76M, up 10.66% year-over-year. In the year 2025, Allgens Medical Technology CO., LTD. had annual revenue of 223.74M with 8.59% growth.
Revenue (ttm)
227.76M
Revenue Growth
+10.66%
P/S Ratio
11.80
Revenue / Employee
840.46K
Employees
271
Market Cap
2.69B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 223.74M | 17.70M | 8.59% |
| Dec 31, 2024 | 206.03M | -20.44M | -9.03% |
| Dec 31, 2023 | 226.48M | -18.83M | -7.68% |
| Dec 31, 2022 | 245.31M | 9.24M | 3.92% |
| Dec 31, 2021 | 236.06M | 52.30M | 28.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.69B |
| Chison Medical Technologies | 441.10M |
| Tellgen | 392.11M |
| Jiangsu Canopus Wisdom Medical Technology | 384.50M |
| Nanjing Medlander Medical Technology | 383.30M |
| Zhejiang Tailin BioEngineering Co.,Ltd | 359.10M |
| Kontour (Xi'an) Medical Technology | 351.72M |
| Beijing Leadman Biochemistry | 317.79M |